BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ge WS, Fan JG. Integrin antagonists are effective and safe for Crohn’s disease: A meta-analysis. World J Gastroenterol 2015; 21(15): 4744-4749 [PMID: 25914486 DOI: 10.3748/wjg.v21.i15.4744]
URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4744.htm
Number Citing Articles
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen, A Barney Hawthorne. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adultsGut 2019; 68(Suppl 3): s1 doi: 10.1136/gutjnl-2019-318484
Seana ML Nelson, Tran M Nguyen, John WD McDonald, John K MacDonald. Natalizumab for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2018; 2018(8) doi: 10.1002/14651858.CD006097.pub3
Peijian He, Abedul Haque, Songbai Lin, Fabio Cominelli, C. Chris Yun. Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na+/H+ exchanger 3 in SAMP1/Fc miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 315(5): G762 doi: 10.1152/ajpgi.00215.2018
Doreen E. Szollosi, Kirsten Hokeness, Mohammed K. Manzoor. Pharmacology of Immunotherapeutic Drugs2020; : 207 doi: 10.1007/978-3-030-19922-7_7
Subrata Ghosh, Brian Bressler, Jill Petkau, Roopal B. Thakkar, Song Wang, Martha Skup, Jingdong Chao, Remo Panaccione, Stefan Schreiber. Healthcare Providers Underestimate Patients’ Glucocorticoid Use in Crohn’s DiseaseDigestive Diseases and Sciences 2019; 64(5): 1142 doi: 10.1007/s10620-018-5419-3